
Keywords: CI; confidence interval; DST; drug susceptibility test; HIV; human immunodeficiency virus; MDR TB; multidrug resistant tuberculosis; MIRU-VNTR; Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat; MTB; Mycobacterium tuberculosis; RFLP